Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zeitschrift fur Gerontologie und Geriatrie·2026
Same author

Zeitschrift fur Gerontologie und Geriatrie·2026
Same author

[40th anniversary of the German Society of Geriatrics (DGG)-In demand, matured, strengthened : History of the DGG concerning scientific and professional political aspects].

Zeitschrift fur Gerontologie und Geriatrie·2025
Same author

[S2e guidelines on the treatment of polymyalgia rheumatica: update 2024 : Evidence-based guidelines of the German Society for Rheumatology and Clinical Immunology (DGRh), the Austrian Society for Rheumatology and Rehabilitation (ÖGR) and the Swiss Society for Rheumatology (SGR) and the participating medical scientific specialist societies and other organizations].

Zeitschrift fur Rheumatologie·2025
Same author

[Rheumatological care in Germany : Memorandum of the German Society for Rheumatology and Clinical Immunology 2024].

Zeitschrift fur Rheumatologie·2024
Same author

[18F-FDG-PET/CT in polymyalgia rheumatica-targeted diagnostics in a selected group of patients].

Zeitschrift fur Rheumatologie·2023

Related Experiment Video

Updated: May 9, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

[Multimorbidity in elderly rheumatic patients part 2].

H-J Lakomek1, T Brabant, M Lakomek

  • 1Klinik für Rheumatologie, physikalische Medizin und Geriatrie, Johannes Wesling Klinikum Minden, Hans-Nolte-Str. 1, 32429, Minden, Deutschland.

Zeitschrift Fur Rheumatologie
|July 23, 2013
PubMed
Summary

Elderly patients with rheumatic diseases face higher risks of multimorbidity, including thyroid dysfunction and type 2 diabetes. Geriatric pharmacotherapy presents unique challenges in managing these complex conditions.

Related Experiment Videos

Last Updated: May 9, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Area of Science:

  • Geriatric Medicine
  • Rheumatology
  • Endocrinology

Context:

  • Rheumatoid arthritis and other systemic rheumatic diseases in the elderly are associated with significant comorbidities.
  • Elderly rheumatic patients frequently experience additional health issues like thyroid dysfunction and type 2 diabetes mellitus.
  • The risk of multimorbidity is substantially elevated in elderly individuals with existing rheumatic conditions.

Purpose:

  • To highlight the increased risk of multimorbidity in elderly rheumatic patients.
  • To discuss the complicating factors in treating elderly rheumatic patients, including cognitive issues and adherence challenges.
  • To address the complexities of geriatric pharmacotherapy and the pharmacokinetics in the elderly.

Summary:

  • Elderly patients with systemic rheumatic diseases often develop multiple comorbidities beyond typical ones like cardiovascular disease and osteoporosis.
  • Thyroid dysfunctions and type 2 diabetes mellitus are common additional conditions, significantly increasing the risk of multimorbidity.
  • Treatment challenges include cognitive impairment, adherence issues, and altered pharmacokinetics in the elderly, necessitating specialized geriatric pharmacotherapy.

Impact:

  • Emphasizes the need for comprehensive management strategies for elderly rheumatic patients.
  • Underscores the importance of considering multimorbidity and geriatric-specific factors in treatment plans.
  • Informs the development of tailored pharmacotherapeutic approaches for this vulnerable population.